The incidence and the mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma

被引：0
|
作者：
Shinohara, N.
Takahashi, M.
Kamishima, T.
Ikushima, H.
Otsuka, N.
Ishizu, A.
Sazawa, A.
Kanayama, H.
Nonomura, K.
机构：
[1] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan
[2] Univ Tokushima, Dept Urol, Grad Sch, Tokushima 770, Japan
[3] Hokkaido Univ Hosp, Dept Radiol, Sapporo, Hokkaido 060, Japan
[4] Tokushima Univ Hosp, Dept Radiol, Tokushima, Japan
[5] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan
[6] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan
[7] Hokkaido Univ, Grad Sch Med, Deaprtment Urol, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15097
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer
    van der Veldt, Astrid A. M.
    Vroling, Laura
    de Haas, Richard R.
    Koolwijk, Pieter
    van den Eertwegh, Alfons J. M.
    Haanen, John B. A. G.
    van Hinsbergh, Victor W. M.
    Broxterman, Henk J.
    Boven, Epie
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) : E484 - E493
  • [32] Assessment of Sunitinib-Induced Toxicities and Clinical Outcomes Based on Therapeutic Drug Monitoring of Sunitinib for Patients With Renal Cell Carcinoma
    Noda, Satoshi
    Otsuji, Takashi
    Baba, Masato
    Yoshida, Tetsuya
    Kageyama, Susumu
    Okamoto, Keisei
    Okada, Yusaku
    Kawauchi, Akihiro
    Onishi, Hiroyuki
    Hira, Daiki
    Morita, Shin-ya
    Terada, Tomohiro
    CLINICAL GENITOURINARY CANCER, 2015, 13 (04) : 350 - 358
  • [33] ASSESSMENT OF SUNITINIB-INDUCED TOXICITIES AND CLINICAL OUTCOMES BASED ON THERAPEUTIC DRUG MONITORING OF SUNITINIB FOR PATIENTS WITH RENAL CELL CARCINOMA
    Terada, Tomohiro
    Noda, Satoshi
    Otsuji, Takashi
    Hira, Daiki
    Morita, Shin-ya
    Yoshida, Tetsuya
    Kageyama, Susumu
    Okamoto, Keisei
    Kawauchi, Akihiro
    DRUG METABOLISM REVIEWS, 2015, 47 : 237 - 238
  • [34] Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Park, Jee Soo
    Koo, Kyo Chul
    Chung, Doo Yong
    Kim, Sun Il
    Kim, Jeongho
    Oh, Cheol Kyu
    Kim, Tae Nam
    Kang, Sung Ku
    Park, Jae Won
    Yoon, Young Eun
    Park, Sung Yul
    Rha, Koon Ho
    Ham, Won Sik
    CANCERS, 2020, 12 (12) : 1 - 11
  • [35] VEGF single nucleotide polymorphisms (SNPs) and correlation to sunitinib-induced hypertension (HTN) in metastatic renal cell carcinoma (mRCC) patients (pts)
    Kim, J. J.
    Vaziri, S. A.
    Elson, P.
    Rini, B. I.
    Ganapathi, M. K.
    Ganapathi, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma
    Nachbargauer, Sebastian
    Bruchbacher, Andreas
    Fajkovic, Harun
    Remzi, Mesut
    Schmidinger, Manuela
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : E277 - E283
  • [37] SUNITINIB RECHALLANGE IN METASTATIC RENAL CELL CARCINOMA PATIENTS
    Nagyivanyi, K.
    Biro, K.
    Gyergyay, F.
    Kueronya, Z.
    Nemeth, H.
    Geczi, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 281 - 281
  • [38] Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma Patients
    Zama, Ivan N.
    Hutson, Thomas E.
    Elson, Paul
    Cleary, James M.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    Ramaiya, Nikhil
    Michaelson, M. Dror
    Garcia, Jorge A.
    Knox, Jennifer J.
    Escudier, Bernard
    Rini, Brian I.
    CANCER, 2010, 116 (23) : 5400 - 5406
  • [39] Overcoming sunitinib-induced resistance by dose escalation in renal cell carcinoma: Evidence in animal models and patients
    Pili, Roberto
    Adelaiye, Remi
    Miles, Kiersten Marie
    Ciamporcero, Eric
    Sotomayor, Paula
    Bjarnason, Georg A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
    Meta H. M. Diekstra
    Xiaoyan Liu
    Jesse J. Swen
    Epie Boven
    Daniel Castellano
    Hans Gelderblom
    Ron H. J. Mathijssen
    Cristina Rodríguez-Antona
    Jesus García-Donas
    Brian I. Rini
    Henk-Jan Guchelaar
    European Journal of Clinical Pharmacology, 2015, 71 : 1477 - 1484
12345